UNSPSC 41202046: Poliovirus serological reagents

In this classification, Poliovirus serological reagents are devices used in test to identify specific Poliovirus antibodies in serum. US FDA regulates Poliovirus serological reagents under 21 CFR 866.3405 and under FDA product code GOH.

UNSPSC 41202046 Poliovirus serological reagents is a Commodity code, but the recent state and local opportunities posted under it reflect minimal alignment with poliovirus-specific testing. Instead, the code shows activity centered on HIV, Syphilis, and Hepatitis screening assays, reagents, and related laboratory testing services. State and local governments are procuring rapid diagnostic test kits, fourth-generation combination screening assays, reagent supplies, and automated instrumentation for public health agencies and corrections departments. Issuing bodies include state health departments (Illinois Department of Public Health), county corrections supervision agencies (Collin County), city public health programs (City of Austin), and special-purpose testing operators (Texas Department of Criminal Justice). The Illinois Department of Public Health appears as a repeat buyer, soliciting multiple times for HIV, Syphilis, and Hepatitis testing capability across different laboratory locations and procurement timelines.

Recent activity concentrates in Illinois, Texas, and Florida. The Illinois Department of Public Health issued an emergency sole-source procurement to Abbott Laboratories for HIV and Syphilis reagents totaling $38,079.50, and an Invitation for Bid for a five-year Hepatitis/HIV/Syphilis combination screening assay and instrumentation contract with up to five additional renewal years, requiring fully automated multi-analyte testing capability and delivery to Carbondale, Illinois by March 16, 2026. In Texas, Collin County's Community Supervision and Corrections Department posted an RFP on July 9, 2026 (due July 23, 2026) for offender specimen collection and drug testing services across Plano and McKinney locations, with an estimated contract value of $600,000 and a two-year term commencing September 1, 2026, plus optional one-year renewals. The City of Austin issued an Invitation for Bid on June 15, 2026 (due July 17, 2026) for rapid HIV Type 1 and Type 2 test kits and controls, requesting Abbott Determine products at estimated annual volumes of 375 test kits and 79 control units on an all-inclusive pricing basis. The code shows little recent activity actually aligned with poliovirus serology; the posted opportunities represent mismatch between the code's nominal scope and the diagnostics state and local jurisdictions are currently buying.